PubRank

J M Cosset

Author PubWeight™ 75.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 2000 2.58
2 Application of the LQ model to the interpretation of absorbed dose distribution in the daily practice of radiotherapy. Radiother Oncol 1991 2.01
3 Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. Blood 1991 1.88
4 The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alpha-initiated apoptosis. Br J Cancer 1998 1.75
5 ICRP publication 112. A report of preventing accidental exposures from new external beam radiation therapy technologies. Ann ICRP 2009 1.73
6 Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: preliminary correlations with local control and overall survival. Int J Radiat Oncol Biol Phys 1993 1.60
7 Prognostic value of tumor regression during radiotherapy for head and neck cancer: a prospective study. Int J Radiat Oncol Biol Phys 1995 1.52
8 Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies. J Clin Oncol 2000 1.44
9 Radiotherapy after ovarian transposition: ovarian function and fertility preservation. Int J Radiat Oncol Biol Phys 1993 1.44
10 Chemoradiotherapy for localized non-Hodgkin's lymphoma. N Engl J Med 1998 1.39
11 Conformal radiotherapy (CRT) planning for lung cancer: analysis of intrathoracic organ motion during extreme phases of breathing. Int J Radiat Oncol Biol Phys 2001 1.07
12 Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literature. Cancer 1989 1.04
13 In vitro parameters and treatment outcome in head and neck cancers treated with surgery and/or radiation: cell characterization and correlations with local control and overall survival. Int J Radiat Oncol Biol Phys 1994 1.03
14 Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study. Radiology 1996 1.03
15 Bone marrow transplantation in 107 patients with severe aplastic anemia using cyclophosphamide and thoraco-abdominal irradiation for conditioning: long-term follow-up. Blood 1991 1.01
16 Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen? Blood 1994 0.96
17 A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of predictive parameters of response to treatment. Int J Radiat Oncol Biol Phys 2001 0.92
18 Analysis by alkaline comet assay of cancer patients with severe reactions to radiotherapy: defective rejoining of radioinduced DNA strand breaks in lymphocytes of breast cancer patients. Int J Cancer 1999 0.92
19 Potential role for low dose limited-field radiation therapy (2 x 2 grays) in advanced low-grade non-Hodgkin's lymphomas. Hematol Oncol 1994 0.92
20 CT and (18)F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers. Int J Radiat Oncol Biol Phys 2001 0.92
21 Increased sensitivity of CLL-derived lymphocytes to apoptotic death activation by the proteasome-specific inhibitor lactacystin. Br J Haematol 1999 0.91
22 Secondary solid malignant tumors occurring after bone marrow transplantation for severe aplastic anemia given thoraco-abdominal irradiation. Radiother Oncol 1994 0.91
23 Unusual localization of cutaneous chronic graft-versus-host disease in the radiation fields in four cases. Bone Marrow Transplant 1989 0.91
24 Male pattern baldness and the risk of prostate cancer. Ann Oncol 2011 0.90
25 In vitro radiation-induced apoptosis and early response to low-dose radiotherapy in non-Hodgkin's lymphomas. Radiother Oncol 1998 0.88
26 In vivo induction of apoptosis in human lymphocytes by therapeutic fractionated total body irradiation. Br J Radiol 1995 0.87
27 Treatment of aggressive multiple myeloma by high-dose chemotherapy and total body irradiation followed by blood stem cells autologous graft. Blood 1989 0.87
28 Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients. Int J Radiat Oncol Biol Phys 1989 0.87
29 [Chemoradiotherapy in locally advanced cancers of the uterine neck. Retrospective study of 92 patients treated at the Institute Curie between 1986 and 1998]]. Cancer Radiother 2002 0.86
30 Cancer of the base of the tongue: past and future. Head Neck 1999 0.84
31 Molecular therapy in support to radiotherapy. Mutat Res 2010 0.84
32 Poor clinical outcome of patients developing malignant solid tumors after bone marrow transplantation for severe aplastic anemia. Leuk Lymphoma 1992 0.84
33 Peripheral blood corticotropin-releasing factor, adrenocorticotropic hormone and cytokine (interleukin beta, interleukin 6, tumor necrosis factor alpha) levels after high- and low-dose total-body irradiation in humans. Radiat Res 1994 0.83
34 The radiation accident in Georgia: clinical appearance and diagnosis of cutaneous radiation syndrome. J Am Acad Dermatol 2000 0.83
35 Consequences of two different doses to the lungs during a single dose of total body irradiation: results of a randomized study on 85 patients. Int J Radiat Oncol Biol Phys 1994 0.83
36 Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. EORTC Lymphoma Cooperative Group. Int J Radiat Oncol Biol Phys 1990 0.83
37 [Biological equivalency of high single doses used in intraoperative irradiation]. Bull Cancer Radiother 1990 0.83
38 Radiation injuries of the gastrointestinal tract in Hodgkin's disease: the role of exploratory laparotomy and fractionation. A study of 19 cases observed in a series of 134 patients treated at the Institut Gustave Roussy from 1972 to 1982. Radiother Oncol 1984 0.83
39 Radiation-induced lung damage after thoracic irradiation for Hodgkin's disease: the role of fractionation. Radiother Oncol 1995 0.82
40 Multicolor flow cytometry analysis of blood cell subsets in patients given total body irradiation before bone marrow transplantation. Int J Radiat Oncol Biol Phys 1995 0.82
41 [Standards, options and recommendations for the practice of external radiotherapy and brachytherapy in oncology. National Federation of Centers for the fight against Cancer]. Bull Cancer 1995 0.81
42 Prognostic factors in non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 1986 0.81
43 Estimation of clonogenic cell fraction in primary cultures derived from human squamous cell carcinomas. Int J Radiat Oncol Biol Phys 1991 0.81
44 Blood cell kinetics and total body irradiation. Radiother Oncol 1987 0.81
45 Low-dose (one gray) total-lymphoid irradiation for extensive, drug-resistant chronic graft-versus-host disease. Transplantation 1990 0.80
46 Post-irradiation hyperamylasemia as a biological dosimeter. Radiother Oncol 1992 0.80
47 [Respiration-gated radiotherapy: current techniques and potential benefits]. Cancer Radiother 2003 0.80
48 [Brachytherapy in the curative treatment of localized prostatic cancer]. Prog Urol 2000 0.79
49 [Hyperplasia of the arterial intima due to smooth muscle cell proliferation. Current data, experimental treatments and perspectives]. J Mal Vasc 2003 0.79
50 [Diagnostic value of vaginal mouldings in uterine cancer (author's transl)]. J Radiol 1979 0.79
51 [The practical application of computer dosimetry in gynaecological radiotherapy. 1,200 cases studied between 1968 and 1976 of the Gustave-Roussy institute (author's transl)]. J Radiol Electrol Med Nucl 1977 0.79
52 Risk of secondary acute leukemia and preleukemia after Hodgkin's disease: the Institut Gustave-Roussy experience. Recent Results Cancer Res 1989 0.79
53 Alternating chemotherapy and radiotherapy for limited-stage intermediate and high-grade non-Hodgkin's lymphomas: long-term results for 96 patients with tumors > 5 cm. Ann Oncol 1996 0.78
54 The never-ending controversy about TBI schedules. Radiother Oncol 1992 0.78
55 Localized stage non-Hodgkin's lymphoma of the testis: a retrospective study of 16 cases. Nouv Rev Fr Hematol 1995 0.78
56 The possible role of radiotherapy in chronic lymphocytic leukaemia: a critical review. Radiother Oncol 1985 0.78
57 Comparative analysis of apoptosis measured by Hoechst and flow cytometry in non-Hodgkin's lymphomas. Cytometry 1998 0.78
58 Combined radiotherapy-chemotherapy for early stages non-Hodgkin's lymphoma: the 1975-1980 EORTC controlled lymphoma trial. Radiother Oncol 1984 0.78
59 The prognostic significance of large mediastinal masses in the treatment of Hodgkin's disease. The experience of the Institut Gustave-Roussy. Hematol Oncol 1984 0.78
60 Prospective study of the clinical symptoms of therapeutic whole body irradiation. Health Phys 1993 0.78
61 [Radiotherapy for breast cancer: respiratory and set-up uncertainties]. Cancer Radiother 2005 0.78
62 [Comparison between single-dose and hyperfractionated total-body irradiation for the conditioning of allogenic grafts of the bone marrow. A retrospective study of 54 patients with malignant hematologic diseases]. Bull Cancer 1988 0.77
63 Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Treatment of Cancer. NCI Monogr 1988 0.77
64 VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin's disease. Bone Marrow Transplant 1998 0.77
65 Autologous hematopoietic stem cell transplantation as salvage treatment for advanced B cell chronic lymphocytic leukemia. Leukemia 1998 0.77
66 Sequencing of drugs and radiation. The integrated alternating regimen. Cancer 1985 0.77
67 In vitro radiation-induced apoptosis and tumour response to radiotherapy: a prospective study in patients with non-Hodgkin lymphomas treated by low-dose irradiation. Int J Radiat Biol 1997 0.77
68 Clinical applications of proton therapy. Experiences and ongoing studies. Radiat Environ Biophys 1995 0.77
69 [Pulmonary and cardiac late effects of ionizing radiations alone or combined with chemotherapy]. Cancer Radiother 1997 0.77
70 Evolution of erythrocyte sedimentation rate as predictor of early relapse in posttherapy early-stage Hodgkin's disease. J Clin Oncol 1988 0.77
71 Successful chemotherapy including epirubicin in a pregnant non-Hodgkin's lymphoma patient. Leuk Lymphoma 1995 0.76
72 Myocardial perfusion damage after mediastinal irradiation for Hodgkin's disease: a thallium-201 single photon emission tomography study. Eur J Nucl Med 1992 0.76
73 Histopathological and cellular studies of a case of cutaneous radiation syndrome after accidental chronic exposure to a cesium source. Radiat Res 1999 0.76
74 Childhood Hodgkin's disease in Campinas, Brazil. Med Pediatr Oncol 1996 0.76
75 Thoracic CT-scanning follow-up of residual mediastinal masses after treatment of Hodgkin's disease. Radiother Oncol 1988 0.75
76 Therapeutic implications and sites of relapse predicted by elevated posttherapy erythrocyte sedimentation rate in early stage Hodgkin disease. Am J Hematol 1991 0.75
77 [Breast cancer: can tamoxifen, under certain conditions, have adverse effects?]. Bull Cancer 1991 0.75
78 Blood lymphocyte subsets after the first fraction in patients given hyperfractionated total body irradiation for bone marrow transplantation. Br J Cancer 1991 0.75
79 Thallium-201 scintigraphy is not predictive of late cardiac complications in patients with Hodgkin's disease treated with mediastinal radiation. Int J Radiat Oncol Biol Phys 2000 0.75
80 Similar effects on murine haemopoietic compartment of low dose rate single dose and high dose rate fractionated total body irradiation. Preliminary results after a unique dose of 750 cGy. Br J Cancer 1990 0.75
81 Hematopoiesis research in aplastic anaemia induced by accidental protracted radiation. C R Acad Sci III 1996 0.75
82 Electron beam irradiation of conjunctival lymphomas. Int J Radiat Oncol Biol Phys 1991 0.75
83 Current trend in the treatment of Hodgkin's disease. Radiat Med 1985 0.75
84 Linitis plastica after Hodgkin's disease. Lancet 1993 0.75
85 [Soft physicians and hard oncologists]. Bull Cancer 1991 0.75
86 [To publish in French or in English? That is the question ...]. Bull Cancer 1992 0.75
87 [Streptococcus B meningitis after splenic irradiation of Hodgkin's disease]. Presse Med 1989 0.75
88 [Primary lymphoma of the central nervous system. Review of recent literature data]. Bull Cancer 1991 0.75
89 [Therapeutic approaches of hematopoietic syndrome following accidental total whole body irradiation]. Bull Cancer 1996 0.75
90 [Non-Hodgkin's malignant lymphomas of the nasopharynx. Apropos of 24 cases treated at the Institut Gustave-Roussy]. Ann Otolaryngol Chir Cervicofac 1987 0.75
91 [Total body irradiation: current indications]. Cancer Radiother 1998 0.75
92 Technical aspects of interstitial hyperthermia. Recent Results Cancer Res 1986 0.75
93 [Current data on malignant mesothelioma. Histochemical characterization of hyaluronic acid]. J Fr Med Chir Thorac 1972 0.75
94 [Irradiation of liver metastasis for analgesia purposes]. Nouv Presse Med 1977 0.75
95 Experimental studies of various heating procedures for clinical application of localized hyperthermia. Prog Clin Biol Res 1982 0.75
96 [Biological basis of total body irradiation]. Cancer Radiother 1999 0.75
97 Molecular biology HLA typing after a 10 Gy-4 hour therapeutic total body irradiation. Health Phys 1994 0.75
98 [Immediate hematologic tolerance of extended irradiations after chemotherapy. Apropos of 78 cases of Hodgkin's disease stage III and IV without marrow involvement treated at the Gustave-Roussy Institute]. Bull Cancer 1991 0.75
99 [Go France ... ASCO/AACR congress, San Diego I, 17-23 May 1992]. Bull Cancer 1992 0.75
100 [No histology, no treatment]. Bull Cancer 1993 0.75
101 [Concentrated irradiation of bone metastasis (author's transl)]. J Radiol Electrol Med Nucl 1977 0.75
102 [Whole body irradiation in the conditioning of bone marrow transplantation. Current indications and limiting factors]. Ann Med Interne (Paris) 1989 0.75
103 [Radioprotection and radiotherapy: the new regulatory texts]. Cancer Radiother 1998 0.75
104 [Electric current and high frequency wave heating processes (author's transl)]. J Radiol 1979 0.75
105 [Predictive tests of response to radiotherapy. Assessment and perspectives in 1997]. Cancer Radiother 1997 0.75
106 [Malignant non-Hodgkin's lymphoma of the conjunctiva. Apropos of 14 cases treated at the Institut Gustave-Roussy]. Bull Cancer Radiother 1990 0.75
107 [Combined chemo- and radiotherapy in multiple pulmonary metastases of cylindroma. A preliminary note (author's transl)]. Nouv Presse Med 1980 0.75
108 [Exposure of patients to radiation risk in common medical practice]. Rev Prat 1995 0.75
109 Technical basis for the application of localized hyperthermia. Strahlentherapie 1983 0.75
110 [Non-small-cell bronchial cancers: improvement of survival probability by conformal radiotherapy]. Cancer Radiother 2002 0.75
111 [Is there still a place for radiation therapy in the management of non-Hodgkin's lymphoma?]. Bull Cancer Radiother 1996 0.75
112 [Adjuvant treatment of colonic cancer. An important progress?]. Bull Cancer 1990 0.75
113 Combined chemotherapy and irradiation for transitional cell cancer of the bladder: a review. J Infus Chemother 1995 0.75
114 Radiological protection in medicine: work of ICRP Committee 3. Ann ICRP 2012 0.75
115 [Veno-occlusive disease of the liver after bone marrow graft. Possible value of fractionation of whole body irradiation]. Presse Med 1987 0.75
116 [Cerebral localization of Hodgkin disease: case report and review of the literature]. Cancer Radiother 2002 0.75
117 [Prognostic factors and treatment of localized Hodgkin's disease]. Rev Prat 1998 0.75
118 [Indications for curietherapy of the prostate using permanent implants]. Cancer Radiother 2002 0.75
119 The value of adjunctive radiotherapy when chemotherapy is the major curative method. Int J Radiat Oncol Biol Phys 1990 0.75
120 [Thoracic manifestations in Kahler's disease (apopos of 3 cases)]. Poumon Coeur 1972 0.75
121 [Treatment of cancer by hyperthermia]. Rev Infirm 1981 0.75
122 [Pulmonary toxicity of antimitotic agent-radiotherapy combination]. Therapie 1987 0.75
123 Role of immunosuppressive drugs for prevention of graft-v-host disease after human HLA matched bone marrow transplantation. Transplant Proc 1987 0.75
124 [Perspectives of hyperthermia in the treatment of tumors of the maxillofacial region]. Rev Stomatol Chir Maxillofac 1982 0.75
125 [Treatment of non-Hodgkin's lymphomas in adults, stages III and IV with favorable histology : abstention or therapeutic aggressiveness?]. Bull Cancer 1983 0.75
126 Interstitial thermoradiotherapy: a technical and clinical study of 29 implantations performed at the Institut Gustave-Roussy. Int J Hyperthermia 1986 0.75
127 Follow-up thallium-201 scintigraphy after mantle field radiotherapy for Hodgkin's disease. Int J Radiat Oncol Biol Phys 1993 0.75
128 Accuracy in mantle field irradiations: irradiated volume and daily dose. Radiother Oncol 1993 0.75
129 [Blood amylase: a biological marker in irradiation accidents? Preliminary results obtained at the Gustave-Roussy Institut (GRI) and a literature review]. Bull Cancer 1989 0.75
130 Treatment of multiple myeloma by high dose chemotherapy, total body irradiation and autologous blood stem cell autograft. Nouv Rev Fr Hematol 1989 0.75
131 [A quality control program for radiotherapy in Hodgkin's disease]. Cancer Radiother 1999 0.75
132 [Hodgkin's disease: from gross tumor volume to clinical target volume, firm data and unresolved problems]. Cancer Radiother 2001 0.75
133 Genetic susceptibility to radiations. Which impact on medical practice? Q J Nucl Med 2000 0.75
134 The contribution of clinical trials to the treatment of patients with early stages of Hodgkin's disease. Drugs Exp Clin Res 1986 0.75
135 [Radiosensitizers of hypoxic cells]. Rev Prat 1989 0.75
136 [Primitive digestive localizations of malignant non-Hodgkin's lymphoma. Prognostic factors of locally advanced disease: stage II. Report of 67 cases]. Gastroenterol Clin Biol 1990 0.75
137 [Cancer of the prostate]. Cancer Radiother 2002 0.75
138 [Biological basis of combined chemo-radiotherapy. Applications to lung cancers]. Cancer Radiother 1997 0.75
139 Non-Hodgkin's lymphoma. Cancer Surv 1985 0.75
140 [External ionizing radiation on the prosthesis-arterial anastomosis for the prevention of intimal hyperplasia and study of biomechanical resistance. Experiments and results]. Ann Chir 2003 0.75
141 Modified bolus technique for the treatment of Kaposi's sarcoma. Int J Radiat Oncol Biol Phys 1988 0.75
142 [Tumor radiosensitivity tests: state of assays in 1998]. Cancer Radiother 1999 0.75
143 [Strategy of radiological exploration in Hodgkin's disease]. Ann Radiol (Paris) 1984 0.75
144 Combined interstitial hyperthermia and brachytherapy: Institute Gustave Roussy technique and preliminary results. Int J Radiat Oncol Biol Phys 1984 0.75
145 Biologic and anatomic problems of lung shielding in whole-body irradiation. J Natl Cancer Inst 1986 0.75
146 [Estimation of the probability of mediastinal involvement: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy in non-small-cell lung cancer?]. Cancer Radiother 2001 0.75
147 [Kahler's disease with subcostal plasmacytoma, pleurisy and plasma cell pericarditis]. Sem Hop 1972 0.75
148 [A combined radiochemotherapy trial for non-small cell lung cancers: initial results]. Cancer Radiother 1997 0.75
149 [Brachytherapy of the prostatic cancer by interstitial permanent implantation of iodine-125]. Cancer Radiother 2002 0.75
150 [Hyperthermia main techniques (author's transl)]. Bull Cancer 1981 0.75
151 [Evaluation of remission after chemotherapy in Hodgkin's disease]. Nouv Presse Med 1982 0.75
152 [Intracranial localization of Hodgkin's disease. Apropos of 2 cases]. Bull Cancer 1989 0.75
153 [Gene transfer and radiotherapy]. Bull Cancer 1996 0.75
154 Blood cell kinetics after a 385 cGy total body irradiation given to a CML patient for bone marrow transplantation. Bone Marrow Transplant 1991 0.75
155 [Radiotherapy in children]. Soins 1979 0.75
156 [Advantages of thoracic CT scanning in the treatment of mediastinal lymphomas]. Bull Cancer 1982 0.75
157 [Localized or metastatic cancer of the prostate: review of new treatment modalities]. Bull Cancer 1998 0.75
158 [A projector of iridium 192 wires: motivations and preliminary studies (author's transl)]. J Radiol 1979 0.75
159 [CT and MR image fusion using two different methods after prostate brachytherapy: impact on post-implant dosimetric assessment]. Cancer Radiother 2003 0.75
160 [Radiotherapy vs. chemotherapy in early-stage Hodgkin's disease: a justified approach?]. Bull Cancer 1992 0.75
161 [Radiosensitivity of lymphocytes. Possible therapeutic impact]. Biomed Pharmacother 1985 0.75
162 [Ionizing radiation and hyperplasia of the intimal matrix: current data and perspectives]. J Mal Vasc 2002 0.75
163 Low-frequency (0.5-MHz) contact and interstitial techniques for clinical hyperthermia. Prog Clin Biol Res 1982 0.75
164 [Clinical value of the potential doubling time (Tpot) measured by flow cytometry]. Bull Cancer 1995 0.75
165 [High-dose external ionizing radiation prevents intimal hyperplasia and limits secretion of growth factors PDGFbb, bFGF, and TGFb1. Experiments and results]. J Mal Vasc 2003 0.75
166 [Value of granisetron in the prevention of digestive disorders in total body irradiation]. Bull Cancer Radiother 1994 0.75
167 Bone marrow transplantation (BMT) for acquired severe aplastic anaemia (SAA): long term follow-up of 107 consecutive patients. Bone Marrow Transplant 1991 0.75
168 High incidence of secondary myelodysplastic syndromes following PROMACE-MOPP and involved field radiotherapy for localized gastric non-Hodgkin's lymphomas. Hematol Oncol 1996 0.75
169 [Standards, options and recommendations for the management of adult patients with Hodgkin disease. Standards, Options and Recommendations (SOR) in Cancerology. Groupe d'Etude des Lymphomes de l'Adulte]]. Presse Med 2000 0.75
170 Hodgkins disease. Br J Cancer 2001 0.75
171 [Secondary neoplasms after allograft of bone marrow. Role of irradiation]. Bull Cancer 1992 0.75
172 Persistent improved results after adding vincristine and bleomycin to a cyclophosphamide/hydroxorubicin/Vm-26/prednisone combination (CHVmP) in stage III-IV intermediate- and high-grade non-Hodgkin's lymphoma. The EORTC Lymphoma Cooperative Group. Ann Oncol 1997 0.75
173 An alternating chemotherapy and radiotherapy combination for non-Hodgkin's lymphomas of unfavourable histologies: feasibility and preliminary results. Radiother Oncol 1985 0.75
174 [Value of multiple daily doses in radiotherapy: hyperfractionation]. Rev Prat 1990 0.75
175 [Radiotherapy. Radiobiological notions, main side effects]. Rev Prat 1997 0.75
176 [Pericarditis after radiotherapy for breast cancer]. Bull Cancer 1985 0.75
177 [Focus on research and results of unusual radiotherapy technics (heavy particles, hyperthermia, radiosensitizers)]. Ann Med Interne (Paris) 1989 0.75
178 [Therapeutic problems in 2 patients with Hodgkin's disease and HIV 1 positive serology]. Bull Cancer 1988 0.75
179 [Upper aerodigestive tract cancers: clinical benefits of conformal radiotherapy and intensity modulation]. Cancer Radiother 2002 0.75
180 Embryonal rhabdomyosarcoma of the vagina in children: conservative treatment with curietherapy and chemotherapy. Eur J Cancer 1979 0.75
181 Fractionated or single-dose total body irradiation in 171 acute myeloblastic leukemias in first complete remission: is there a best choice? SFGM. Société Française de Greffe de Moelle. Int J Radiat Oncol Biol Phys 1995 0.75
182 [Conformal radiotherapy: revolution or evolution?]. Cancer Radiother 1999 0.75
183 [Radiotherapy-induced solid tumors: review of the literature and risk assessment]. Cancer Radiother 1998 0.75
184 [Constraints and dosage for prostate cancer patients treated with conformal radiotherapy and intensity modulated radiation therapy]. Cancer Radiother 2004 0.75
185 [Interstitial techniques of hyperthermia (author's transl)]. Bull Cancer 1981 0.75
186 Combined chemoradiation for locally advanced nonsmall cell lung cancer. J Infus Chemother 1995 0.75